Status:
COMPLETED
Examining the Individual Response to a Restricted Sodium Diet in Hypertensive Patients
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Hypertension
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Excessive dietary sodium intake is an independent risk factor for hypertension and cardiovascular disease. A vast array of efforts have tried to reduce sodium consumption based on evidence indicating ...
Eligibility Criteria
Inclusion
- Systolic blood pressure of 120-159 mmHg or diastolic blood pressure of 80-99 mmHg, whether or not taking blood pressure medications.
- Smartphone with a data plan
- Valid email address
- Willing and able to participate in online study videoconferencing visits (Zoom)
- Reads and writes in English
Exclusion
- Participating in another related research study
- Cardiovascular disease event (e.g. stroke, myocardial infarction) in prior 6 months
- Active cancer
- Recent hospitalization due to psychiatric condition or event
- Pregnancy or breastfeeding - current or planned during the study period
- Documented dementia
- Prisoners
- Diabetes Diagnosis
- Heart Failure Diagnosis
Key Trial Info
Start Date :
February 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04764253
Start Date
February 11 2021
End Date
September 30 2023
Last Update
June 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229